> top > projects > sentences > docs > PubMed:27124553 > annotations
sentences Home  

PubMed:27124553 JSONTXT 11 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-131 Sentence denotes Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia.
T1 0-131 Sentence denotes Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia.
TextSentencer_T2 132-233 Sentence denotes OBJECTIVE: sFLT-1 e15a is a recently described sFlt-1 variant that is placental and primate specific.
T2 132-233 Sentence denotes OBJECTIVE: sFLT-1 e15a is a recently described sFlt-1 variant that is placental and primate specific.
TextSentencer_T3 234-280 Sentence denotes As such, it may have potential as a biomarker.
T3 234-280 Sentence denotes As such, it may have potential as a biomarker.
TextSentencer_T4 281-416 Sentence denotes Using a newly developed ELISA, we measured maternal plasma sFLT-1 e15a levels in women with fetal growth restriction and pre-eclampsia.
T4 281-416 Sentence denotes Using a newly developed ELISA, we measured maternal plasma sFLT-1 e15a levels in women with fetal growth restriction and pre-eclampsia.
TextSentencer_T5 417-424 Sentence denotes METHOD:
T5 417-424 Sentence denotes METHOD:
TextSentencer_T6 425-543 Sentence denotes We performed a nested case-control study where we measured total sFLT-1 and sFLT-1 e15a plasma protein concentrations.
T6 425-543 Sentence denotes We performed a nested case-control study where we measured total sFLT-1 and sFLT-1 e15a plasma protein concentrations.
TextSentencer_T7 544-725 Sentence denotes Samples, selected from a prospective cohort study, consisted of 87 healthy controls, 11 cases that developed term preeclampsia and 20 cases where there was fetal growth restriction.
T7 544-725 Sentence denotes Samples, selected from a prospective cohort study, consisted of 87 healthy controls, 11 cases that developed term preeclampsia and 20 cases where there was fetal growth restriction.
TextSentencer_T8 726-809 Sentence denotes We also measured sFLT-1 and sFLT-1 e15a plasma concentrations in a separate cohort:
T8 726-809 Sentence denotes We also measured sFLT-1 and sFLT-1 e15a plasma concentrations in a separate cohort:
TextSentencer_T9 810-867 Sentence denotes 15 cases of preterm preeclampsia and 24 healthy controls.
T9 810-867 Sentence denotes 15 cases of preterm preeclampsia and 24 healthy controls.
TextSentencer_T10 868-876 Sentence denotes RESULTS:
T10 868-876 Sentence denotes RESULTS:
TextSentencer_T11 877-1020 Sentence denotes The prospective case-control cohort demonstrated significantly increased sFLT-1 e15a among cases with term fetal growth restriction (p < 0.05).
T11 877-1020 Sentence denotes The prospective case-control cohort demonstrated significantly increased sFLT-1 e15a among cases with term fetal growth restriction (p < 0.05).
TextSentencer_T12 1021-1203 Sentence denotes We also observed that total sFLT-1 (this ELISA indiscriminately detects all variants) was significantly increased in term preeclampsia (p < 0.0001), but not fetal growth restriction.
T12 1021-1203 Sentence denotes We also observed that total sFLT-1 (this ELISA indiscriminately detects all variants) was significantly increased in term preeclampsia (p < 0.0001), but not fetal growth restriction.
TextSentencer_T13 1204-1316 Sentence denotes The separate cohort of early-onset preeclamptics showed significantly increased sFLT-1 e15a levels (p < 0.0001).
T13 1204-1316 Sentence denotes The separate cohort of early-onset preeclamptics showed significantly increased sFLT-1 e15a levels (p < 0.0001).
TextSentencer_T14 1317-1328 Sentence denotes CONCLUSION:
T14 1317-1328 Sentence denotes CONCLUSION:
TextSentencer_T15 1329-1437 Sentence denotes Plasma sFLT-1 e15a is significantly increased in early-onset preeclampsia and term fetal growth restriction.
T15 1329-1437 Sentence denotes Plasma sFLT-1 e15a is significantly increased in early-onset preeclampsia and term fetal growth restriction.
TextSentencer_T16 1438-1560 Sentence denotes Further assessment of the benefit for sFLT-1 e15a testing in prediction or diagnosis of these disease states is warranted.
T16 1438-1560 Sentence denotes Further assessment of the benefit for sFLT-1 e15a testing in prediction or diagnosis of these disease states is warranted.